These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 34157302)

  • 1. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.
    Marangoni F; Zhakyp A; Corsini M; Geels SN; Carrizosa E; Thelen M; Mani V; Prüßmann JN; Warner RD; Ozga AJ; Di Pilato M; Othy S; Mempel TR
    Cell; 2021 Jul; 184(15):3998-4015.e19. PubMed ID: 34157302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
    Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
    Holt MP; Punkosdy GA; Glass DD; Shevach EM
    J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
    Ovcinnikovs V; Ross EM; Petersone L; Edner NM; Heuts F; Ntavli E; Kogimtzis A; Kennedy A; Wang CJ; Bennett CL; Sansom DM; Walker LSK
    Sci Immunol; 2019 May; 4(35):. PubMed ID: 31152091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
    Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
    Lu Y; Schneider H; Rudd CE
    Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement.
    Wang CJ; Heuts F; Ovcinnikovs V; Wardzinski L; Bowers C; Schmidt EM; Kogimtzis A; Kenefeck R; Sansom DM; Walker LS
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):524-9. PubMed ID: 25548162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunity.
    Watanabe T; Ishino T; Ueda Y; Nagasaki J; Sadahira T; Dansako H; Araki M; Togashi Y
    Cancer Sci; 2023 May; 114(5):1859-1870. PubMed ID: 36762794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
    Panda AK; Kim YH; Shevach EM
    J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.
    Marangoni F; Zhang R; Mani V; Thelen M; Ali Akbar NJ; Warner RD; Äijö T; Zappulli V; Martinez GJ; Turka LA; Mempel TR
    J Immunol; 2018 May; 200(10):3647-3661. PubMed ID: 29661826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
    Ohue Y; Nishikawa H
    Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
    J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8
    Semmrich M; Marchand JB; Fend L; Rehn M; Remy C; Holmkvist P; Silvestre N; Svensson C; Kleinpeter P; Deforges J; Junghus F; Cleary KL; Bodén M; Mårtensson L; Foloppe J; Teige I; Quéméneur E; Frendéus B
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Rebound in IL-12-Treated Tumors Is Driven by Uncommitted Peripheral Regulatory T Cells.
    Li Q; Virtuoso LP; Anderson CD; Egilmez NK
    J Immunol; 2015 Aug; 195(3):1293-300. PubMed ID: 26085681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.
    Zenke S; Palm MM; Braun J; Gavrilov A; Meiser P; Böttcher JP; Beyersdorf N; Ehl S; Gerard A; Lämmermann T; Schumacher TN; Beltman JB; Rohr JC
    Immunity; 2020 Feb; 52(2):313-327.e7. PubMed ID: 32049052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
    Ha D; Tanaka A; Kibayashi T; Tanemura A; Sugiyama D; Wing JB; Lim EL; Teng KWW; Adeegbe D; Newell EW; Katayama I; Nishikawa H; Sakaguchi S
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):609-618. PubMed ID: 30587582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.